FOSTER DYKEMA CABOT & PARTNERS, LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 2011882
WALTHAM, MA
Position in VRTX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$28,926,078
+$3,119,639 QoQ
Shares Held
58,233
+0.8% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
2.66%
of 13F equity value
Holder Rank
#214
of 1,735 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FOSTER DYKEMA CABOT & PARTNERS, LLC holds $28,939,970 across 5 Biotechnology names. VRTX ranks #1 (100.0% of the industry book) .
All Filings in VRTX
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,926,078 | 58,233 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $25,806,439 | 57,792 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $26,450,835 | 58,344 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $23,768,239 | 60,689 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $27,122,919 | 60,923 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $29,794,613 | 61,455 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $24,509,932 | 60,864 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $27,797,831 | 59,770 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $28,111,482 | 59,975 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $24,965,647 | 59,725 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $23,366,065 | 57,426 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||